220 related articles for article (PubMed ID: 6966821)
1. Studies of anti-lymphocyte antibody in patients with active SLE. II. Effect of anti-lymphocyte antibody on autoreactive cell clones.
Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
Scand J Immunol; 1980; 11(5):479-88. PubMed ID: 6966821
[TBL] [Abstract][Full Text] [Related]
2. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function.
Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
Scand J Immunol; 1979; 10(3):213-21. PubMed ID: 160612
[TBL] [Abstract][Full Text] [Related]
3. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
4. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
[TBL] [Abstract][Full Text] [Related]
5. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
6. Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.
Bankhurst AD; Williams RC
J Clin Invest; 1975 Dec; 56(6):1378-85. PubMed ID: 1081549
[TBL] [Abstract][Full Text] [Related]
7. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
8. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
Winfield JB; Shaw M; Minota S
J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanism of DNA-specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients.
Takeuchi T; Abe T; Koide J; Hosono O; Morimoto C; Homma M
Arthritis Rheum; 1984 Jul; 27(7):766-73. PubMed ID: 6611160
[TBL] [Abstract][Full Text] [Related]
10. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production.
Voll RE; Roth EA; Girkontaite I; Fehr H; Herrmann M; Lorenz HM; Kalden JR
Arthritis Rheum; 1997 Dec; 40(12):2162-71. PubMed ID: 9416853
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
13. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
Spronk PE; vd Gun BT; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1993 Jul; 93(1):39-44. PubMed ID: 8100746
[TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
15. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.
Mihaylova N; Chipinski P; Bradyanova S; Velikova T; Ivanova-Todorova E; Chausheva S; Herbáth M; Kalinova D; Prechl J; Kyurkchiev D; Tchorbanov AI
Clin Exp Immunol; 2020 Mar; 199(3):278-293. PubMed ID: 31724735
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus. Some contemporary laboratory aspects.
Deegan MJ
Arch Pathol Lab Med; 1980 Aug; 104(8):399-404. PubMed ID: 6967303
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous production of antibodies to deoxyribonucleic acids in patients with systemic lupus erythematosus.
Takeuchi T
Clin Immunol Immunopathol; 1985 Apr; 35(1):47-56. PubMed ID: 3873304
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.
Okudaira K; Tanimoto K; Aikawa T; Horiuchi Y; Aotsuka S
Scand J Rheumatol; 1983; 12(1):21-8. PubMed ID: 6601298
[TBL] [Abstract][Full Text] [Related]
19. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.
Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C
Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic responses to lipopolysaccharide by B lymphocytes from patients with systemic lupus erythematosus.
Abe T; Toguchi T; Takeuchi T; Kiyotaki M; Homma M
Scand J Immunol; 1981 May; 15(5):475-82. PubMed ID: 6213030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
